SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,460 | -16.9% | 135 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $18,607 | +6.4% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,493 | +16.6% | 135 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $15,000 | +50.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -9.1% | 135 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $11,000 | -8.3% | 135 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $12,000 | -20.0% | 135 | -18.2% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +200.0% | 165 | +153.8% | 0.00% | +100.0% |
| Q2 2021 | $5,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 65 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +22.2% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -10.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +66.7% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -25.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |